Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Appl Thromb Hemost ; 26: 1076029620966051, 2020.
Article in English | MEDLINE | ID: mdl-33112684

ABSTRACT

Saudi women have recently started using oral contraceptives (OCs), which has led to risk of venous thromboembolism (VTE). The risk varies with the type of OC generations used, and with OC use the risk for VTE increases by 2- to 6-fold. This study evaluated the effect of OC types in relation to ABO blood group on the risk of VTE among Saudi women. Thrombin generation (TG) was measured in the plasma of the women in the presence and absence of platelet rich plasma, platelet poor plasma and thrombomodulin or activated protein C. OC usage increased TG parameters ETP and Peak height by 9.81% and 16.04%, respectively. An increased risk of VTE was seen among women on third generation OCs as compared to those on second generation products. Within OC generations, we found that for women using fourth generation OCs, their ETP increased by 36.18% as compared to those using second generation and by 6.07% in those using third generation compared to those using second generation. There was significant difference with respect to ABO blood groups and OC generation types, but larger sample size is required. Women who are 40 years and older and using third generation OC had a higher risk of having thrombosis (11.84%), as compared to those using second generation OC (8.79%) and to those using fourth generation OC (5.03%). An association between different OC groups and non-O blood group in thrombosis generation was noted. TG parameters were significantly increased in relation to BMI when comparing to OC users versus non-users. In addition, inhibition of TG parameters in the presence of recombinant human thrombomodulin (TM) and activated protein C (APC) were significantly increased.


Subject(s)
Contraceptives, Oral/adverse effects , Venous Thromboembolism/chemically induced , ABO Blood-Group System/blood , Adult , Age Factors , Blood Coagulation/drug effects , Body Mass Index , Female , Humans , Protein C/analysis , Risk Factors , Saudi Arabia/epidemiology , Venous Thromboembolism/blood , Venous Thromboembolism/epidemiology , Young Adult
2.
Asian Pac J Cancer Prev ; 15(6): 2547-54, 2014.
Article in English | MEDLINE | ID: mdl-24761862

ABSTRACT

BACKGROUND: To evaluate the perception of cancer patients toward treatment services and influencing factors and to inquire about the use of complementary alternative medicine (CAM). MATERIALS AND METHODS: Information was obtained through pre-tested structured questionnaires completed by cancer patients during treatment at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. RESULTS: Of 242 patients, 137 (64.6%) accepted to enter this study. Most were Saudi (n=93, 68%), female (n= 80, 58%), educated at university (n=71, 52%), married (n=97, 72%) and with breast cancer (n=36, 26%). One-hundred (73%) patients were satisfied with the services provided; 61% were Saudi. Ninety-four (68%) respondents were satisfied with the explanation of their cancer. Twenty-eight (21.6%) patients received CAM, of them 54.0% received herbal followed by rakia (21.0%), nutritional supplements/vitamins (7.0%) and Zamam water (18.0%), with significant differences among them (p =0.004). Seven (5%) patients believed this therapy could be used alone; 34 (25%) patients believed it could be used with other treatments, regardless of whether they themselves used this therapy. Fifty-three (53%) satisfied patients felt they received enough support; 31 (58%) patients received support from family and friends; 22 (41.6%) patients received support from the health-care team. Patients who received information about their disease from their physicians and those who felt they had enough support were more satisfied. The patients who took alternative treatment were older age, mostly female and highly educated but values did not reach significance. CONCLUSIONS: We stress enhancing the educational and supportive aspects of cancer-patient services to improve their treatment satisfaction and emphasize the need for increasing the educational and awareness programs offered to these patients.


Subject(s)
Complementary Therapies/statistics & numerical data , Delivery of Health Care/organization & administration , Health Services/statistics & numerical data , Neoplasms/therapy , Patient Satisfaction , Perception , Adult , Aged , Cross-Sectional Studies , Disease Management , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasms/psychology , Prognosis , Saudi Arabia , Surveys and Questionnaires
3.
Biol Trace Elem Res ; 131(3): 215-28, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19337698

ABSTRACT

Chromium deficiency is associated with impaired glucose tolerance (IGT) and dyslipidemia. Hence, the objective of the current study was to investigate chromium status among Saudi men with and without established cardiovascular disease (CVD) and its relationship to glucose tolerance, lipid profile and other established CVD risk factors. We measured serum and urine chromium concentrations, fasted lipid profile, plasma glucose, and serum lipid peroxide in 130 Saudi men with an established history of myocardial infarction and 130 age-matched controls without established CVD. Patients with established CVD had higher serum triglycerides (p < 0.05) and plasma glucose (p < 0.0001) and lower serum and urinary chromium concentrations (p < 0.0001) than controls. Serum chromium was inversely correlated with plasma glucose among cases and controls (r = -0.189, p < 0.05 and r = -0.354, p < 0.00001, respectively). Plasma glucose (OR 1.127, CI 1.0-1.269, p < 0.05), serum chromium (OR 0.99, CI 0.985-0.995, p < 0.0001), and urinary chromium (OR 0.988, CI 0.981-0.995, p < 0.001) were independently associated with the presence of established coronary disease applying this model. While chromium metabolism appears to be altered in individuals with CVD, it is unclear whether chromium supplementation would be effective in CVD prevention among patients with IGT. This would need to be tested in long-term outcome trials.


Subject(s)
Chromium/deficiency , Coronary Artery Disease/blood , Adult , Aged , Blood Glucose/metabolism , Case-Control Studies , Chromium/blood , Chromium/urine , Coronary Artery Disease/etiology , Coronary Artery Disease/prevention & control , Coronary Artery Disease/urine , Glucose Tolerance Test , Humans , Lipid Peroxides/blood , Lipids/blood , Male , Middle Aged , Myocardial Infarction/blood , Myocardial Infarction/etiology , Myocardial Infarction/prevention & control , Myocardial Infarction/urine , Risk Factors , Saudi Arabia
4.
Molecules ; 14(1): 141-59, 2008 Dec 31.
Article in English | MEDLINE | ID: mdl-19127244

ABSTRACT

The purpose of this research was to investigate the relationship between selenium levels, thyroid function and other coronary risk factors in 140 Saudi subjects without overt coronary heart disease stratified by age. Demographic data and serum fasting lipid profile, glucose, thyroid function tests, selenium status and dietary intake was assessed. The relationships between selenium status, thyroid function and cardiovascular risk factors were assessed by univariate and multivariate analysis. The results showed that thyroid hormone levels did not differ with age. Erythrocyte glutathione peroxidase (GPx) levels were significantly higher in the youngest vs. oldest tertile (p<0.0001). Selenium and iodine intake did not differ significantly with age tertile, but the average intake for the population sample was below the estimated average requirements for both elements. Serum lipoprotein (a) concentrations correlated with selenium (r = 0.417, p<0.0001) and TSH (r = 0.172, p<0.05). After adjustment for confounding variables; serum fT(4) and erythrocytes GPx remained significant determinants of serum TSH levels, whilst serum selenium and TSH were determinants of serum fT(4) levels. Serum Lp(a), a coronary risk factor, was strongly related to measures of selenium status. A significant relationship between measures of selenium status and thyroid function was found. Serum Lp(a) a known risk factor for cardiovascular disease was also related to selenium status in our population.


Subject(s)
Cardiovascular Diseases/epidemiology , Selenium/analysis , Thyroid Gland/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Blood Glucose/analysis , Erythrocytes/enzymology , Glutathione Peroxidase/metabolism , Humans , Iodine/analysis , Iodine/blood , Iodine/urine , Lipoproteins/blood , Male , Middle Aged , Multivariate Analysis , Risk Factors , Saudi Arabia/epidemiology , Selenium/blood , Selenium/urine , Thyroid Hormones/analysis , Thyroid Hormones/blood , Thyroid Hormones/urine , Young Adult
5.
J Trace Elem Med Biol ; 21(4): 242-54, 2007.
Article in English | MEDLINE | ID: mdl-17980815

ABSTRACT

There have been inconsistent reports on the relationship between iron status and coronary artery diseases (CAD), and little data on this relationship in non-Caucasian populations. We assessed dietary iron by questionnaire and measured serum iron and ferritin levels in 270 Saudi male subjects without established CAD, 130 of whom were angiogram negative. Serum lipid profile, glucose, high sensitivity-C reactive protein (hs-CRP), serum soluble intercellular adhesion molecules-1 (sICAM-1), and caeruloplasmin were measured in all subjects. The angiogram negative patients, had lower serum ferritin (p<0.05) and iron (p<0.0001) levels than the 140 subjects without reported cardiovascular diseases (CVD). Serum iron correlated with serum triglycerides (p<0.0001) and total cholesterol (p<0.05) levels for this latter group and the groups combined. Serum ferritin correlated with serum total cholesterol and low-density lipoprotein (LDL)-cholesterol in the combined group (p<0.05), and was correlated with blood glucose and serum LDL-cholesterol (p<0.05) in the subjects without reported CVD. After adjustment for confounding variables, serum iron levels remained a significant correlate with total calorie intake and serum triglycerides. Serum ferritin also correlated significantly with cholesterol intake and fasting serum total cholesterol. Dietary iron was significantly related to dietary cholesterol and fiber, age, smoking habits, and serum total cholesterol level. Hence, indices of iron status were related to several coronary risk factors in the Saudi population.


Subject(s)
Coronary Disease/blood , Diabetes Mellitus/blood , Iron/blood , Metabolic Syndrome/blood , Adolescent , Adult , Aged , Aged, 80 and over , Animals , Biomarkers/blood , Ferritins/blood , Food , Humans , Iron, Dietary , Male , Middle Aged , Multivariate Analysis , Risk Factors , Saudi Arabia , Surveys and Questionnaires
6.
J Trace Elem Med Biol ; 20(2): 105-14, 2006.
Article in English | MEDLINE | ID: mdl-16785050

ABSTRACT

BACKGROUND: Traditional coronary risk factors do not fully explain variations in the incidence of cardiovascular disease (CVD). Epidemiological studies have implicated perturbations in selenium, copper, and zinc metabolism in the aetiology of CVD. However, these studies have been principally undertaken in Caucasian populations, in whom trace element intake is generally sufficient. METHOD: We have measured serum and urine selenium, copper, and zinc; and superoxide dismutase, glutathione peroxidase, and lipid peroxide concentrations in 130 Saudi male subjects with established CVD, and 130 age-matched controls. RESULTS: Diabetes mellitus, positive smoking habit (p<0.0001 for both), and hypertension (p<0.05) were more prevalent among CVD patients. Urinary copper (p<0.0001) and zinc (p<0.05) were higher among controls. Serum selenium concentrations were lower among CVD patients (p<0.001), and a high proportion (52%) had selenium levels below 79mug/L compared to controls (22%) (p<0.0001). Conditional logistic regression analysis, showed the characteristics differentiating CVD patients from controls were serum zinc (odds ratio (OR) 0.92, confidence interval (CI) 0.85-0.99, p<0.05), serum copper/zinc ratio (OR 0.31, CI 0.10-0.96), serum selenium (OR 0.07, CI 0.02-0.31, p<0.0001), and urine selenium (OR 3.34, CI 1.40-7.99, p<0.01). CONCLUSION: Measures of trace metals status appear to be associated with the risk of atherosclerosis in a Saudi male population.


Subject(s)
Atherosclerosis , Copper , Selenium , Trace Elements , Zinc , Adult , Age Factors , Aged , Atherosclerosis/blood , Atherosclerosis/urine , Copper/blood , Copper/urine , Demography , Diet , Glutathione Peroxidase/blood , Glutathione Peroxidase/urine , Humans , Lipid Peroxides/blood , Lipid Peroxides/urine , Male , Middle Aged , Multivariate Analysis , Risk Factors , Saudi Arabia , Selenium/blood , Selenium/urine , Superoxide Dismutase/blood , Superoxide Dismutase/urine , Trace Elements/blood , Trace Elements/urine , Zinc/blood , Zinc/urine
7.
Clin Chim Acta ; 365(1-2): 288-96, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16213478

ABSTRACT

BACKGROUND: The relationship between coronary risk score (CRS), individual coronary risk factors and the serum inflammatory markers, high sensitivity C-reactive protein (hsCRP), ceruloplasmin (Cp), and soluble intercellular adhesion molecule-1 (sICAM-1) was studied in 140 Saudi males without clinically evident coronary heart disease (CHD). METHODS: One hundred forty subjects without clinically evident CHD were categorized into age tertiles. Demographic data together with an estimate of CRS using Framingham and PROCAM algorithms were obtained, and serum lipid profile, glucose, hsCRP, sICAM-1, and Cp were measured. Macronutrient intake was assessed by a questionnaire. The relationship between CRS, biochemical markers and diet was assessed by univariate and multivariate analysis. RESULTS: There was no significant difference in median hsCRP, sICAM-1 or Cp between the age groups. Serum Cp was positively associated with age (r=0.224, p<0.01) and FRS score (r=0.174, p<0.05). Serum sICAM-1 was negatively associated with PROCAM score (r=-0.183, p<0.05). sICAM-1 was positively associated with HDL cholesterol (r=0.36, p<0.0001) among non-diabetics and negatively associated (r=-0.397, p<0.05) among diabetic subjects. Age and dietary intake of saturated fatty acids together explained 7.9% of the variation in serum Cp level in a stepwise multiple regression model. Similarly 6.5% of the variation in serum sICAM-1 level was explained by the total cholesterol/HDL-C ratio. The youngest tertile of the group (<30 y) had the highest dietary intake of energy, fat and saturated fatty acids (p<0.05), and also had a high prevalence of obesity, smoking and sedentary lifestyle. CONCLUSION: We have demonstrated that there is a high prevalence of coronary risk factors and poor dietary intake within a Saudi male population, and that dietary factors are associated with serum sICAM-1 and ceruloplasmin but not hsCRP concentrations in this group.


Subject(s)
Biomarkers , Cardiovascular Diseases/epidemiology , Dietary Fats/administration & dosage , Inflammation/blood , Adult , Cardiovascular Diseases/blood , Cardiovascular Diseases/physiopathology , Humans , Male , Multivariate Analysis , Risk Factors , Saudi Arabia/epidemiology
8.
Asia Pac J Clin Nutr ; 14(2): 137-44, 2005.
Article in English | MEDLINE | ID: mdl-15927930

ABSTRACT

Traditional risk factors do not appear to explain fully the variation in the incidence of the cardiovascular diseases (CVD). Epidemiological studies have not been entirely consistent with regard to the relationship between antioxidant vitamin intake and CVD and there appears to be little data on this relationship in non-Caucasian populations. This study aimed to investigate the dietary intake of vitamin A, C, and vitamin E, and carotenoids, serum concentrations of vitamin E and A and indices of lipid peroxidation were measured in male Saudi patients with established CVD and age-matched controls. We assessed the dietary intakes of vitamins A, C, and E and carotenoids, by a food frequency questionnaire. Serum vitamins A and E concentrations were measured by HPLC, in 130 Saudi male subjects with established CVD, and 130 age-matched controls. We also determined serum lipid profiles (total cholesterol, triglycerides, HDL-C, LDL-C), lipoprotein (a), oxidized LDL, and serum lipid peroxide concentrations. Diabetes mellitus (P<0.0001), a positive smoking habit (P<0.0001) and hypertension (P<0.05) were more prevalent among CVD patients. Levels of dietary vitamin E and A were also significantly higher among cases. In conditional logistic regression analysis, the most significant characteristics differentiating CVD patients from controls were diabetes mellitus (Odds ratio 2.49, CI 1.42-4.37, P<0.001), total fat intake (Odds ratio 1.02, CI 1.01-1.03, P<0.01), serum vitamin A (Odds ratio 0.72, CI 0.53-0.99, P<0.05), and the vitamin A/total fat intake ratio (Odds ratio 1.04, CI 1.01-1.06, P<0.01). In a Saudi population, smoking habit and hypertension were significantly more common among patients with CVD. Multivariate analysis showed that dietary total fat and vitamin A and the presence of diabetes mellitus were independent coronary risk factors. This is the first report of a potentially deleterious effect of dietary vitamin A in a non-Caucasian population. However it is possible that unidentified residual confounding factors may account for this finding.


Subject(s)
Ascorbic Acid/administration & dosage , Cardiovascular Diseases/epidemiology , Carotenoids/administration & dosage , Vitamin A/administration & dosage , Vitamin E/administration & dosage , Antioxidants/administration & dosage , Antioxidants/metabolism , Ascorbic Acid/blood , Body Mass Index , Cardiovascular Diseases/blood , Carotenoids/blood , Case-Control Studies , Cholesterol/blood , Chromatography, High Pressure Liquid , Diabetes Mellitus/epidemiology , Dietary Fats/administration & dosage , Dietary Fats/metabolism , Humans , Hypertension/epidemiology , Lipid Peroxidation , Logistic Models , Male , Middle Aged , Multivariate Analysis , Prevalence , Risk Factors , Saudi Arabia/epidemiology , Smoking , Surveys and Questionnaires , Vitamin A/adverse effects , Vitamin A/blood , Vitamin E/adverse effects , Vitamin E/blood
SELECTION OF CITATIONS
SEARCH DETAIL